CD274 and central nervous system cancer: A total number of 874 GBM (731 de-novo and 143 recurrent glioma) were analysed and showed a significant down-regulation of PD-L1 in recurrent glioblastoma (reduction of 88,25% p=0.00268), Figure 1C.